• About
  • Advertise
  • Contact
Tuesday, February 3, 2026
  • Login
No Result
View All Result
NEWSLETTER
The NY Journals
  • Home
  • Business
  • Technology
  • Entertainment
  • Sports
  • Lifestyle
  • Health
  • Politics
  • Trending
  • Home
  • Business
  • Technology
  • Entertainment
  • Sports
  • Lifestyle
  • Health
  • Politics
  • Trending
No Result
View All Result
The NY Journals
No Result
View All Result
Home Technology

China bans imports of Illumina’s gene sequencers right after Trump tariff action

by Sarkiya Ranen
in Technology
China bans imports of Illumina’s gene sequencers right after Trump tariff action
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter


CHINA announced a ban on Tuesday (Mar 4) on imports of genetic sequencers from US medical equipment maker Illumina, just minutes after US President Donald Trump’s additional 10 per cent tariff on Chinese goods took effect.

The ban is part of a series of measures China announced in response to the extra US tariffs and comes after Beijing put Illumina on its “unreliable entity” list in February.

China accounts for about 7 per cent of Illumina’s sales. Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic variations associated with diseases and diagnose rare genetic conditions.

The ban takes effect from Mar 4.

China’s commerce ministry said in a statement that Illumina had suspended normal transactions with Chinese enterprises and taken discriminatory measures against them.

Responding to Reuters queries, Illumina said it would continue to serve its customers in China and was “committed to operating in compliance with the latest guidelines from the Ministry of Commerce”.

BT in your inbox

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

It said the company was assessing the announcement to fully understand the impact on its operations in China.

Beijing refrained from punishing big US household names, as it did when it retaliated against the Trump administration’s February four tariffs, but Illumina was the most high-profile company hit by the latest measures from China.

The company has been under growing scrutiny from Beijing, after two of its Chinese rivals, MGI and BGI, were listed in a US bill that aims to restrict business with several biotech companies on grounds of national security. MGI and BGI have denied such allegations.

Shares in BGI Genomics, a subsidiary of BGI, jumped 8.4 per cent on Tuesday and MGI Tech, a listed MGI entity, soared by the daily limit of 20 per cent, on prospects for taking market share in China from their US rival.

Nomura revised up its earnings forecast for MGI Tech and estimated the ban could create a potential 750 million-yuan (S$138.5 million) business opportunity for the Chinese firm this year.

In February, China also put PVH Corp, the holding company for brands including Calvin Klein and Tommy Hilfiger, on its unreliable entity list and announced an investigation into Google as part of a wide range of measures targeting US businesses.

Companies added to the list can be subject to fines and a broad range of other sanctions, including a freeze on trade and revocation of work permits for foreign staff. REUTERS



Source link

Tags: ActionBansChinaGeneIlluminasImportssequencersTariffTrump
Sarkiya Ranen

Sarkiya Ranen

I am an editor for Ny Journals, focusing on business and entrepreneurship. I love uncovering emerging trends and crafting stories that inspire and inform readers about innovative ventures and industry insights.

Next Post
“I’ve Seen Him”: UP Speaker Slams MLA For Spitting ‘Pan Masala’ In Assembly

"I've Seen Him": UP Speaker Slams MLA For Spitting 'Pan Masala' In Assembly

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Peter Crouch delivers perfect response to Erling Haaland robot celebration

Peter Crouch delivers perfect response to Erling Haaland robot celebration

3 months ago
Stocks to watch: UOB, CapitaLand Investment 

Stocks to watch: UOB, CapitaLand Investment 

1 year ago

Popular News

    Connect with us

    The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.

    Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.

    NEWS

    • Business
    • Technology
    • Entertainment
    • Sports
    • Lifestyle
    • Health
    • Politics
    • Real Estate
    Instagram Youtube

    © 2025 The New York Journals. All Rights Reserved.

    • About Us
    • Advertise
    • Contact Us
    No Result
    View All Result
    • Home
    • Business
    • Technology
    • Entertainment
    • Sports
    • Lifestyle
    • Health
    • Politics
    • Trending

    Copyright © 2023 The Nyjournals

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In